What You Should Know:
- Ryse Health, a healthcare technology company that’s committed to pursuing a world free from chronic diseases and raising the bar on Type 2 Diabetes care raises $6.5M in Series A funding led by Route 66 Ventures. The round also included support from W Health and Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield.
- The company plans to use the funding to enable Ryse to continue to grow its team, strengthen its business operations, partner
Read More
Detroit Pistons Selects Progyny for Value-Based Family Building Care
What You Should Know:
- Progyny, a fertility benefits company pioneering value-based care, announced that they have partnered with the Detroit Pistons, to provide comprehensive, equitable family building care for employees and their families.
- Through this partnership, the Detroit Pistons will have access to equitable and comprehensive family building care that its diverse workforce requires.
Comprehensive, Value-Based Family Building Care
With Progyny, Detroit Pistons
Read More
Mayo’s Lucem Health Launches AI-Driven Early Disease Detection Platform
What You Should Know:
- Lucem Health™ today announced the availability of its new early AI-driven disease detection solutions, Lucem Health Reveal that leverages existing EHR data to identify patients who may be at a higher risk of serious or chronic disease.
- Reveal solutions surface previously undiscovered insights in readily available clinical data that can help provider organizations deliver greater clinical value for patients and more financial value to the organization.
Early
Read More
Tempus, Pfizer Partner to Advance Oncology Therapeutic Development
What You Should Know:
- Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology.
- Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights that will power therapeutic development in oncology.
-
Read More
Hospitals Enter 2023 Facing ‘New Normal’ of Financial Uncertainty
What You Should Know:
- Hospitals enter 2023 on more stable footing following the worst financial year since the start of the pandemic—but challenges persist, according to the newest data from Kaufman Hall.
- The latest National Hospital Flash Report finds that hospitals continue to experience the same challenges that made 2022 the worst financial year since the start of the pandemic, including higher labor expenses, lower patient volumes, and a fundamental
Read More
Walmart & CareSource Partner to Address Racial Health Inequities
What You Should Know:
- Today, Walmart announced a three-year agreement with the nonprofit organization, CareSource to address cardiometabolic conditions and maternal health in under-resourced and underserved communities.
- The partnership expands the work Walmart and CareSource are doing to help improve care around maternal and child health in Georgia - the two launched a pilot in Georgia earlier this year to help Black maternal health across the state.
Address
Read More
CodaMetrix Raises $55M for AI-Powered, Autonomous Medical Coding
What You Should Know:
- CodaMetrix, an AI technology platform transforming healthcare revenue cycle management, today announced that it closed a $55 million Series A round led by SignalFire. Frist Cressey Ventures (FCV), Martin Ventures, Yale Medicine, University of Colorado Healthcare Innovation Fund, and Mass General Brigham physician organizations also participated in the round.
- The capital injection will accelerate go-to-market with major provider organizations and health systems, as
Read More
Portfolia Invests in Xandar Kardian for Health Monitoring
What You Should Know:
- Portfolia, the world’s most powerful community of women investors, has officially announced a significant investment in Xandar Kardian from the firm’s Active Aging I and Active Aging II funds. Portfolia’s investment represents a core contribution to Xandar Kardian’s $10 million Series A Funding round.
- Portfolia sees Xandar Kardian’s impact extends well beyond the traditional hospital room, with impressive potential growth opportunities into a wider
Read More
ObvioHealth Launches Digital Therapeutics API for Clinical Trials
What You Should Know:
- ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials.
- ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors with accurate data to correlate efficacy with adherence to the DTx. In addition, ObvioGo’s integration reduces participant task duplication because—in most cases—outcomes can be passively captured
Read More
Eko Launches Cardiac Disease Detection Platform, SENSORA
What You Should Know:
- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform.
- SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
Eko SENSORA Cardiac Disease Detection
Read More
